CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
multiparametric MRI on the bladder +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05324033
NCT05324033N/ACompleted
CompareCT.gov

Sensitivity of Multiparametric MRI in Differentiation Between Muscle Invasive and Non-muscle Invasive Urinary Bladder Cancer

Helwan University·observational·Posted Apr 12, 2022·Updated Apr 4, 2023

In Brief

An observational study evaluating multiparametric MRI on the bladder and diagnostic cystoscopy +/- TURBT for Cancer, Bladder. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) is a cornerstone in the treatment plans.Therefore, this study will try to evaluate the sensitivity and reliability of mpMRI in accurate diagnosis of cancer bladder. Primary objective: to detect the sensitivity of multiparametric MRI in differentiation between muscle Invasive and non-muscle invasive Urinary Bladder Cancer in relation to the conventional cystoscopy and histopathological examination of the biopsy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Bladder
CountriesEgypt
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 12, 2022
Enrollment StartMay 1, 2022
Primary CompletionFeb 1, 2023
Study CompletionApr 1, 2023
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 4.2 years ago

Interventions

multiparametric MRI on the bladderradiation

comparison between mpMRI and histopathology

diagnostic cystoscopy +/- TURBTprocedure

conventional way of diagnosis